HYBRID EVENT: You can participate in person at Tokyo, Japan from your home or work.
AI is playing an increasingly crucial role in personalized cancer therapies, where treatment plans are tailored to the individual characteristics of both the patient and their cancer. By analyzing a patient’s genetic makeup, AI can predict how the cancer will respond to various treatments, allowing for more precise and targeted therapies. This leads to improved treatment outcomes, fewer side effects, and the ability to tailor the intensity and type of treatment to match the patient's unique needs. Moreover, AI systems can continuously monitor a patient’s progress, adjusting therapies as necessary to maximize effectiveness. The ability to provide customized cancer care through AI is advancing personalized medicine and offers the hope of better, more efficient cancer treatments.
